Mantle Cell Lymphoma Global Clinical Trials Review, H1, 2012

Summary

companys clinical trial report, “Mantle Cell Lymphoma Global Clinical Trials Review, H1, 2012 provides data on the Mantle Cell Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mantle Cell Lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mantle Cell Lymphoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by companys team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Tables 5
List of Figures 7
Introduction 8
Mantle Cell Lymphoma 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Mantle Cell Lymphoma 25
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Mantle Cell Lymphoma Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
SymBio Pharmaceuticals Limited 35
Clinical Trial Overview of SymBio Pharmaceuticals Limited 35
Takeda Pharmaceutical Company Limited 36
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 36
Celgene Corporation 37
Clinical Trial Overview of Celgene Corporation 37
Cephalon, Inc. 38
Clinical Trial Overview of Cephalon, Inc. 38
F. Hoffmann-La Roche Ltd. 39
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 39
Sanofi 40
Clinical Trial Overview of Sanofi 40
Amgen Inc. 41
Clinical Trial Overview of Amgen Inc. 41
BioMarin Pharmaceutical Inc. 42
Clinical Trial Overview of BioMarin Pharmaceutical Inc. 42
Novartis AG 43
Clinical Trial Overview of Novartis AG 43
Merck & Co., Inc. 44
Clinical Trial Overview of Merck & Co., Inc. 44
Pharmacyclics, Inc. 45
Clinical Trial Overview of Pharmacyclics, Inc. 45
Piramal Life Sciences Limited 46
Clinical Trial Overview of Piramal Life Sciences Limited 46
Telik, Inc. 47
Clinical Trial Overview of Telik, Inc. 47
MethylGene Inc 48
Clinical Trial Overview of MethylGene Inc 48
Celldex Therapeutics, Inc. 49
Clinical Trial Overview of Celldex Therapeutics, Inc. 49
Onyx Pharmaceuticals, Inc. 50
Clinical Trial Overview of Onyx Pharmaceuticals, Inc. 50
Sunesis Pharmaceuticals, Inc. 51
Clinical Trial Overview of Sunesis Pharmaceuticals, Inc. 51
GlaxoSmithKline plc 52
Clinical Trial Overview of GlaxoSmithKline plc 52
Millennium Pharmaceuticals, Inc. 53
Clinical Trial Overview of Millennium Pharmaceuticals, Inc. 53
Clinical Trial Overview of Top Universities / Institutes / Hospitals 54
Fred Hutchinson Cancer Research Center 54
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 54
The University of Texas M. D. Anderson Cancer Center 56
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 56
Mayo Clinic 57
Clinical Trial Overview of Mayo Clinic 57
Weill Cornell Medical College 58
Clinical Trial Overview of Weill Cornell Medical College 58
Stanford University 59
Clinical Trial Overview of Stanford University 59
Duke University 60
Clinical Trial Overview of Duke University 60
Groupe Ouest Est dEtude des Leucemies et Autres Maladies du Sang GOELAMS 61
Clinical Trial Overview of Groupe Ouest Est dEtude des Leucemies et Autres Maladies du Sang GOELAMS 61
City of Hope National Medical Center 62
Clinical Trial Overview of City of Hope National Medical Center 62
University of Wisconsin Madison 63
Clinical Trial Overview of University of Wisconsin Madison 63
Massachusetts General Hospital 64
Clinical Trial Overview of Massachusetts General Hospital 64
H. Lee Moffitt Cancer Center & Research Institute 65
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 65
University of Pennsylvania 66
Clinical Trial Overview of University of Pennsylvania 66
Case Comprehensive Cancer Center 67
Clinical Trial Overview of Case Comprehensive Cancer Center 67
Wake Forest University 68
Clinical Trial Overview of Wake Forest University 68
Southwest Oncology Group 69
Clinical Trial Overview of Southwest Oncology Group 69
Ohio State University Comprehensive Cancer Center 70
Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 70
Groupe dEtudes de Lymphomes de LAdulte 71
Clinical Trial Overview of Groupe dEtudes de Lymphomes de LAdulte 71
Memorial Sloan-Kettering Cancer Center 72
Clinical Trial Overview of Memorial Sloan-Kettering Cancer Center 72
Thomas Jefferson University 73
Clinical Trial Overview of Thomas Jefferson University 73
University Hospital, Bordeaux 74
Clinical Trial Overview of University Hospital, Bordeaux 74
Five Key Clinical Profiles 75
Appendix 123
Abbreviations 123
Definitions 123
Research Methodology 124
Secondary Research 124
About company 125
Contact Us 125
Disclaimer 125
Source 126

List of Tables

Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Mantle Cell Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
Mantle Cell Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
Mantle Cell Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
Mantle Cell Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15
Mantle Cell Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16
Mantle Cell Lymphoma Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Mantle Cell Lymphoma Therapeutics Clinical Trials, G7 Countries, 2012* 18
Mantle Cell Lymphoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Mantle Cell Lymphoma Therapeutics Clinical Trials, E7 Countries, 2012* 20
Mantle Cell Lymphoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Mantle Cell Lymphoma Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
Mantle Cell Lymphoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
Mantle Cell Lymphoma Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27
Mantle Cell Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 28
Mantle Cell Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 30
Mantle Cell Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 32
Mantle Cell Lymphoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 34
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by SymBio Pharmaceuticals Limited, 2012* 35
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2012* 36
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 37
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 2012* 38
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 39
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 40
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 41
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by BioMarin Pharmaceutical Inc., 2012* 42
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 43
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 44
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2012* 45
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Piramal Life Sciences Limited, 2012* 46
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Telik, Inc., 2012* 47
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by MethylGene Inc, 2012* 48
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celldex Therapeutics, Inc., 2012* 49
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Onyx Pharmaceuticals, Inc., 2012* 50
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunesis Pharmaceuticals, Inc., 2012* 51
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 52
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Millennium Pharmaceuticals, Inc., 2012* 53
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 54
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 56
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 57
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2012* 58
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 59
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 60
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe Ouest Est dEtude des Leucemies et Autres Maladies du Sang GOELAMS, 2012* 61
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012* 62
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2012* 63
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 64
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012* 65
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2012* 66
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 67
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 68
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2012* 69
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2012* 70
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe dEtudes de Lymphomes de LAdulte, 2012* 71
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan-Kettering Cancer Center, 2012* 72
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2012* 73
Mantle Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2012* 74

List of Figures

Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Mantle Cell Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
Mantle Cell Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
Mantle Cell Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
Mantle Cell Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 15
Mantle Cell Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16
Mantle Cell Lymphoma Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
Mantle Cell Lymphoma Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
Mantle Cell Lymphoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Mantle Cell Lymphoma Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
Mantle Cell Lymphoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
Mantle Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Mantle Cell Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 28
Mantle Cell Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
Mantle Cell Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
Mantle Cell Lymphoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33
company Methodology 124